Search research articles
Contact Us
Filters
Showing results (61-70 of 159) with videos related to
Page
of 16
Sort By:
CNS Drugs
|
December 16, 2015
Novel GLP-1 (Glucagon-Like Peptide-1) Analogues and Insulin in the Treatment for Alzheimer's Disease and Other Neurodegenerative Diseases
Valeria Calsolaro, Paul Edison
Journal of Alzheimer'S Disease : JAD
|
October 18, 2024
Incretin Mimetics as Potential Disease Modifying Treatment for Alzheimer's Disease
Harry Crook, Paul Edison
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
|
June 17, 2016
Alterations in Glucose Metabolism in Alzheimer's Disease
Valeria Calsolaro, Paul Edison
Nature Reviews. Neurology
|
December 15, 2020
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
Fangda Leng, Paul Edison
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 16, 2016
Neuroinflammation in Alzheimer's disease: Current evidence and future directions
Valeria Calsolaro, Paul Edison
Current Neurology and Neuroscience Reports
|
June 8, 2019
Tau Imaging in Neurodegenerative Diseases Using Positron Emission Tomography
Yi Ting Wang, Paul Edison
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Rifa Sanjida Punnota, Paul Edison
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 18, 2014
Evaluation of neuroprotective effect of glucagon-like peptide 1 analogs using neuroimaging
Grazia D Femminella, Paul Edison
Journal of Alzheimer'S Disease : JAD
|
June 6, 2018
Role of Neuroinflammation in the Trajectory of Alzheimer's Disease and in vivo Quantification Using PET
Paul Edison, David J Brooks
BMJ (Clinical Research Ed.)
|
March 15, 2023
Cognitive impairment after cancer treatment: mechanisms, clinical characterization, and management
Ben Fleming, Paul Edison, Laura Kenny
Page
of 16
Search research articles
Search
Showing results (61-70 of 159) with videos related to
Sort By:
Page
of 16
CNS Drugs
|
December 16, 2015
Novel GLP-1 (Glucagon-Like Peptide-1) Analogues and Insulin in the Treatment for Alzheimer's Disease and Other Neurodegenerative Diseases
Valeria Calsolaro, Paul Edison
Journal of Alzheimer'S Disease : JAD
|
October 18, 2024
Incretin Mimetics as Potential Disease Modifying Treatment for Alzheimer's Disease
Harry Crook, Paul Edison
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
|
June 17, 2016
Alterations in Glucose Metabolism in Alzheimer's Disease
Valeria Calsolaro, Paul Edison
Nature Reviews. Neurology
|
December 15, 2020
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
Fangda Leng, Paul Edison
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 16, 2016
Neuroinflammation in Alzheimer's disease: Current evidence and future directions
Valeria Calsolaro, Paul Edison
Current Neurology and Neuroscience Reports
|
June 8, 2019
Tau Imaging in Neurodegenerative Diseases Using Positron Emission Tomography
Yi Ting Wang, Paul Edison
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Rifa Sanjida Punnota, Paul Edison
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 18, 2014
Evaluation of neuroprotective effect of glucagon-like peptide 1 analogs using neuroimaging
Grazia D Femminella, Paul Edison
Journal of Alzheimer'S Disease : JAD
|
June 6, 2018
Role of Neuroinflammation in the Trajectory of Alzheimer's Disease and in vivo Quantification Using PET
Paul Edison, David J Brooks
BMJ (Clinical Research Ed.)
|
March 15, 2023
Cognitive impairment after cancer treatment: mechanisms, clinical characterization, and management
Ben Fleming, Paul Edison, Laura Kenny
Page
of 16